IN2014MU00859A - - Google Patents
Info
- Publication number
- IN2014MU00859A IN2014MU00859A IN859MU2014A IN2014MU00859A IN 2014MU00859 A IN2014MU00859 A IN 2014MU00859A IN 859MU2014 A IN859MU2014 A IN 859MU2014A IN 2014MU00859 A IN2014MU00859 A IN 2014MU00859A
- Authority
- IN
- India
- Prior art keywords
- acceptable derivative
- pharmaceutical
- sulbactam
- stereoisomer
- compound
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN859MU2014 IN2014MU00859A (es) | 2014-03-14 | 2015-01-14 | |
| PCT/IB2015/050267 WO2015136387A1 (en) | 2014-03-14 | 2015-01-14 | Pharmaceutical compositions comprising antibacterial agents |
| EP15706530.1A EP3116545A1 (en) | 2014-03-14 | 2015-01-14 | Pharmaceutical compositions comprising antibacterial agents |
| KR1020167025810A KR20160126004A (ko) | 2014-03-14 | 2015-01-14 | 항세균제를 포함하는 제약학적 조성물 |
| CN201580014021.1A CN106794250A (zh) | 2014-03-14 | 2015-01-14 | 包含抗菌剂的药物组合物 |
| JP2016555984A JP2017507162A (ja) | 2014-03-14 | 2015-01-14 | 抗菌薬を含む医薬組成物 |
| US15/125,562 US20170000775A1 (en) | 2014-03-14 | 2015-01-14 | Pharmaceutical compositions comprising antibacterial agents |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN859MU2014 IN2014MU00859A (es) | 2014-03-14 | 2015-01-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014MU00859A true IN2014MU00859A (es) | 2015-10-02 |
Family
ID=52589710
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN859MU2014 IN2014MU00859A (es) | 2014-03-14 | 2015-01-14 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20170000775A1 (es) |
| EP (1) | EP3116545A1 (es) |
| JP (1) | JP2017507162A (es) |
| KR (1) | KR20160126004A (es) |
| CN (1) | CN106794250A (es) |
| IN (1) | IN2014MU00859A (es) |
| WO (1) | WO2015136387A1 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016151543A1 (en) * | 2015-03-25 | 2016-09-29 | Wockhardt Limited | Pharmaceutical compositions comprising antibacterial agents |
| US11905286B2 (en) | 2018-08-09 | 2024-02-20 | Antabio Sas | Diazabicyclooctanones as inhibitors of serine beta-lactamases |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2842779C (en) * | 2011-07-26 | 2016-04-19 | Wockhardt Limited | Pharmaceutical compositions comprising beta-lactam antibiotic, sulbactam and beta-lactamase inhibitor |
| RU2560846C1 (ru) * | 2011-07-26 | 2015-08-20 | Вокхардт Лимитед | Фармацевтические композиции, содержащие сулбактам и ингибитор бета-лактамазы |
| ES2640520T3 (es) * | 2011-09-13 | 2017-11-03 | Wockhardt Limited | Compuestos que contienen nitrógeno y su uso |
-
2015
- 2015-01-14 IN IN859MU2014 patent/IN2014MU00859A/en unknown
- 2015-01-14 JP JP2016555984A patent/JP2017507162A/ja active Pending
- 2015-01-14 WO PCT/IB2015/050267 patent/WO2015136387A1/en active Application Filing
- 2015-01-14 CN CN201580014021.1A patent/CN106794250A/zh active Pending
- 2015-01-14 EP EP15706530.1A patent/EP3116545A1/en not_active Withdrawn
- 2015-01-14 US US15/125,562 patent/US20170000775A1/en not_active Abandoned
- 2015-01-14 KR KR1020167025810A patent/KR20160126004A/ko not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| KR20160126004A (ko) | 2016-11-01 |
| EP3116545A1 (en) | 2017-01-18 |
| US20170000775A1 (en) | 2017-01-05 |
| CN106794250A (zh) | 2017-05-31 |
| WO2015136387A1 (en) | 2015-09-17 |
| JP2017507162A (ja) | 2017-03-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12018500591A1 (en) | Heterocyclic compounds and uses thereof | |
| TW201613911A (en) | Heterocyclic compounds and uses thereof | |
| GEP20207075B (en) | New aminoacid derivatives, a process for their preparation and pharmaceutical compositions containing them | |
| MA39749A (fr) | Dérivés de pipéridine-dione | |
| TN2015000519A1 (en) | Small molecule inhibitors of fibrosis | |
| MX2016015565A (es) | Ciertos inhibidores de la proteina quinasa. | |
| MX2016013431A (es) | Composiciones farmaceuticas que comprenden agentes antibacterianos. | |
| MY181641A (en) | Amino pyran ring derivative and composition and use thereof | |
| PH12016501252A1 (en) | Novel tetrahydropyridopyrimidine compound or salt thereof | |
| MX2017016619A (es) | Derivados de pirimidina como inhibidores de tirosina cinasa de bruton (btk) y usos de los mismos. | |
| PH12017500459A1 (en) | Azetidinyloxyphenylpyrrolidine compounds | |
| EP3213746A4 (en) | Pharmaceutical composition for oral administration comprising taxane | |
| IN2014CH00840A (es) | ||
| EP3720844A4 (en) | MEDICINAL COMPOSITIONS | |
| PH12017502148A1 (en) | Pharmaceutical compositions and use thereof | |
| TW201613898A (en) | Benzofuran analogue as NS4B inhibitor | |
| IN2014MU00859A (es) | ||
| MA39877A (fr) | Formes solides d'un composé pharmaceutiquement actif | |
| IN2013MU03704A (es) | ||
| IN2013MU03422A (es) | ||
| IN2013MU03421A (es) | ||
| IN2013MU03308A (es) | ||
| IN2013MU03309A (es) | ||
| MX2016013428A (es) | Composiciones farmaceuticas que comprenden agentes antibacterianos. | |
| IN2014MU01194A (es) |